Slide 1: Sales growth, improved earnings and PMA approval for iCast
Sales growth, improved earnings and PMA approval for iCast Getinge Q1 2023 Mattias Perjos, CEO Lars Sandström, CFO
Slide 2: Key takeaways
Key takeaways Q1 2023 • Net sales increased by 7.5% and order intake increased by 2.9% organically • Volume, price increases and positive FX effects contributed to higher adjusted Gross Profit and EBITA • Underlying Free Cash Flow higher than LY adjusted for surgical mesh settlement payout • Solid f
Slide 3: Key activities and events
Key activities and events Q1 2023 Offering and customers • PMA for the iCast™ covered stent system in the US • Acquisition of Ultra Clean Systems in the US • Launch of a new Servo-c ventilator • Increased production capacity for DPTE®-AlphaPort Sustainability and Quality • Continuous improvements wh
Slide 4: Organic sales growth in all regions
Organic sales growth in all regions EMEA stands out positively in the quarter Global Americas EMEA APAC +2.9% Organic Order Growth +7.5% Organic Net Sales Growth Getinge │ Presentation │ Q1 Report 2023 April 26, 2023 Page 4
Slide 5: Outlook 2023
Outlook 2023 Net sales expected to grow 2-5% organically in 2023 Getinge │ Presentation │ Q1 Report 2023 April 26, 2023 Page 5
Slide 6: Healthy order growth in Acute Care Therapies and Surgical Workflows
Healthy order growth in Acute Care Therapies and Surgical Workflows Order Intake Bridge Q1 2022 – Q1 2023 Organic change +5.1% -12.7% +6.6% +2.9% +10.4% 272 495 -63 7,476 6,772 MSEK Q1 2022 Acute Care Therapies Life Science Surgical Workflows Q1 2023 Getinge │ Presentation │ Q1 Report 2023 April 26,
Slide 7: Sales growth supported by improvements in the supply chain and FX
Sales growth supported by improvements in the supply chain and FX Net Sales Bridge Q1 2022 – Q1 2023 Organic change +6.5% -10.3% +19.6% +7.5% 511 +15.5% 482 481 Currency impact, MSEK -35 9.4 MSEK 7,141 6.5 Organic growth, % 6,182 Q1 2022 Acute Care Life Science Surgical Q1 2023 Capital Recurring The
Slide 8: Adj Gross profit positively impacted by volume and FX
Adj Gross profit positively impacted by volume and FX Adjusted Gross Profit Bridge Q1 2022 – Q1 2023 Adj GM, % Q1 2023 61.6 42.6 39.5 52.3 (Q1 2022) (62.2) (43.2) (39.1) (52.7) Gross Margin impact +473 198 Product and Geo mix 295 -21 Supply, Absorption & Cost inflation MSEK 3,734 Price 3,261 Currenc
Slide 9: Financial development
Financial development Getinge │ Presentation │ Q1 Report 2023 April 26, 2023 Page 9
Slide 10: EBITA positively impacted by volume and FX
EBITA positively impacted by volume and FX Adjusted EBITA Bridge Q1 2022 – Q1 2023 13.6% 13.6% Margin development -1.0 pp Adj GP +133 -0.8 pp Adj OPEX 473 +1.2 pp FX +0.6 pp D&A -130 -143 -40 -14 -13 +146 Currency impact, MSEK MSEK 972 839 Q1 2022 Adj Gross Adj Selling Adj Admin Adj R&D Other D&A Q1
Slide 11: Generating healthy underlying FCF, WC days <100 and ROIC back on trend
Generating healthy underlying FCF, WC days <100 and ROIC back on trend Capital efficiency a priority Healthy underlying Free Cash Flow WC days below 100 Return on Invested Capital back on trend 200 1.0 0.7 150 0.4 0.1 14.4% 100 FCF was better than in Q1 -0.7 2022 when adjusted for the Surgical Mesh
Slide 12: Solid financial position even after the payout for Surgical Mesh
Solid financial position even after the payout for Surgical Mesh Low net debt and high margin of safety when it comes to leverage Net debt is down significantly in recent years … … and leverage is signaling financial strength 14.0 3.4x 3.7 1.2 BSEK excl. pension liabilities) 0.6 (0.2 x excluding pen
Slide 13: Summary
Summary Getinge │ Presentation │ Q1 Report 2023 April 26, 2023 Page 13
Slide 14: Key takeaways
Key takeaways Summary Q1 2023 • Strong sales growth and healthy order book – outlook for 2023 reiterated • Growth in adj Gross Profit and adj EBITA • Healthy underlying Free Cash Flow • Solid financial position Getinge │ Presentation │ Q1 Report 2023 April 26, 2023 Page 14
Slide 15: Q&A
Q&A Getinge │ Presentation │ Q1 Report 2023 April 26, 2023 Page 15
Slide 16: Thank you
Thank you Getinge │ Presentation │ Q1 Report 2023 April 26, 2023 Page 16
Slide 17: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of the Getinge’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectation
Slide 18: Getinge - Passion for Life
“= Se A GETINGE PASSION FOR LIFE